VASIRIVA 10 (Rivaroxaban film-coated Tablets 10 mg)

Manufacturer
Hetero Labs Limited(INDIA)

Registraction Number
MAL24096029AZ

Content:

• Active Ingredient: Rivaroxaban 10 mg
• Inactive Ingredients: Various excipients (binders, fillers, etc.)

• Prevent venous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement surgery.
• Treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevent recurrent DVT and PE in adults.

• Dosage:
  • Prevention of VTE: 10 mg taken orally once daily. The initial dose should be taken 6 to 10 hours after surgery, provided that hemostasis has been established1.
  • Treatment of DVT and PE: 15 mg taken orally twice daily for the first three weeks, followed by 20 mg once daily for continued treatment and prevention of recurrent DVT and PE.
• Administration: Swallow the tablet whole with water. Do not crush or chew the tablet.
• Precautions: Inform your doctor if you have any allergies, liver or kidney problems, or if you are pregnant or planning to become pregnant. Avoid using if you have untreated bacterial infections or conditions that increase the risk of bleeding.
• Storage: Store at room temperature, away from moisture and heat.